CD28 and neoplasm: Moreover, the PBL cells have demonstrated, in all types of tumour diseases, an increasing expression of cell surface markers CD8+CD28+ confirming the effectiveness of “cellular therapy” (Figures 6(a), 6(b), 6(c), 6(d), 6(e), and 6(f)).